{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:33:40Z","timestamp":1789205620834,"version":"build-2803163510"},"reference-count":86,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Duke-NUS Medical School"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/10\/039\/28270"],"award-info":[{"award-number":["FS\/10\/039\/28270"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Coronary artery disease (CAD) is a major cause of morbidity and mortality worldwide. Coronary artery bypass graft (CABG) surgery is the revascularisation strategy of choice in patients with diabetes mellitus and complex CAD. Owing to a number of factors, including the ageing population, the increased complexity of CAD being treated, concomitant valve and aortic surgery, and multiple comorbidities, higher-risk patients are being operated on, the result of which is an increased risk of sustaining perioperative myocardial injury (PMI) and poorer clinical outcomes. As such, new treatment strategies are required to protect the heart against PMI and improve clinical outcomes following cardiac surgery. In this regard, the heart can be endogenously protected from PMI by subjecting the myocardium to one or more brief cycles of ischaemia and reperfusion, a strategy called \u201cischaemic conditioning\u201d. However, this requires an intervention applied directly to the heart, which may be challenging to apply in the clinical setting. In this regard, the strategy of remote ischaemic conditioning (RIC) may be more attractive, as it allows the endogenous cardioprotective strategy to be applied away from the heart to the arm or leg by simply inflating and deflating a cuff on the upper arm or thigh to induce one or more brief cycles of ischaemia and reperfusion (termed \u201climb RIC\u201d). Although a number of small clinical studies have demonstrated less PMI with limb RIC following cardiac surgery, three recently published large multicentre randomised clinical trials found no beneficial effects on short-term or long-term clinical outcomes, questioning the role of limb RIC in the setting of cardiac surgery. In this article, we review ischaemic conditioning as a therapeutic strategy for endogenous cardioprotection in patients undergoing cardiac surgery and discuss the potential reasons for the failure of limb RIC to improve clinical outcomes in this setting. Crucially, limb RIC still has the therapeutic potential to protect the heart in other clinical settings, such as acute myocardial infarction, and it may also protect other organs against acute ischaemia\/reperfusion injury (such as the brain, kidney, and liver).<\/ns4:p>","DOI":"10.12688\/f1000research.10963.1","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T11:10:05Z","timestamp":1493118605000},"page":"563","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Is there a role for ischaemic conditioning in cardiac surgery?"],"prefix":"10.12688","volume":"6","author":[{"given":"Luciano","family":"Candilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-4956","authenticated-orcid":false,"given":"Derek","family":"Hausenloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"629-38","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.","volume":"381","author":"F Mohr","year":"2013","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"223-30","DOI":"10.1001\/jamainternmed.2013.12844","article-title":"Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.","volume":"174","author":"I Sipahi","year":"2014","journal-title":"JAMA Intern Med."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"40-4","DOI":"10.1510\/icvts.2007.173922","article-title":"Changing risk of patients undergoing coronary artery bypass surgery.","volume":"8","author":"F Biancari","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"253-65","DOI":"10.1093\/cvr\/cvs131","article-title":"Cardioprotection during cardiac surgery.","volume":"94","author":"D Hausenloy","year":"2012","journal-title":"Cardiovasc Res."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00395-012-0258-4","article-title":"\"Conditional Conditioning\" in cardiac bypass surgery.","volume":"107","author":"D Hausenloy","year":"2012","journal-title":"Basic Res Cardiol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"1124-36","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.","volume":"74","author":"C Murry","year":"1986","journal-title":"Circulation."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"451-9","DOI":"10.1111\/j.1463-1326.2007.00762.x","article-title":"Preconditioning and postconditioning: new strategies for cardioprotection.","volume":"10","author":"D Hausenloy","year":"2008","journal-title":"Diabetes Obes Metab."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","article-title":"Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery.","volume":"111","author":"D Hausenloy","year":"2016","journal-title":"Basic Res Cardiol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"4544-63","DOI":"10.2174\/1381612811319250004","article-title":"Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).","volume":"19","author":"D Hausenloy","year":"2013","journal-title":"Curr Pharm Des."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1293-9","DOI":"10.1161\/01.RES.72.6.1293","article-title":"Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia.","volume":"72","author":"T Kuzuya","year":"1993","journal-title":"Circ Res."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1264-72","DOI":"10.1161\/01.CIR.88.3.1264","article-title":"Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.","volume":"88","author":"M Marber","year":"1993","journal-title":"Circulation."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"448-60","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.","volume":"61","author":"D Hausenloy","year":"2004","journal-title":"Cardiovasc Res."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"217-34","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.","volume":"12","author":"D Hausenloy","year":"2007","journal-title":"Heart Fail Rev."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"87-93","DOI":"10.1007\/s10557-011-6364-y","article-title":"Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart.","volume":"26","author":"D Hausenloy","year":"2012","journal-title":"Cardiovasc Drugs Ther."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"201-8","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.","volume":"84","author":"L Lacerda","year":"2009","journal-title":"Cardiovasc Res."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"32-40","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?","volume":"47","author":"S Lecour","year":"2009","journal-title":"J Mol Cell Cardiol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"607-9","DOI":"10.1016\/j.yjmcc.2009.01.003","article-title":"Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?","volume":"46","author":"S Lecour","year":"2009","journal-title":"J Mol Cell Cardiol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"893-907","DOI":"10.1089\/ars.2010.3360","article-title":"Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin.","volume":"14","author":"D Hausenloy","year":"2011","journal-title":"Antioxid Redox Signal."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"534-43","DOI":"10.1016\/S0008-6363(02)00455-8","article-title":"Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?","volume":"55","author":"D Hausenloy","year":"2002","journal-title":"Cardiovasc Res."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"339-41","DOI":"10.1016\/S0022-2828(03)00043-9","article-title":"The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion.","volume":"35","author":"D Hausenloy","year":"2003","journal-title":"J Mol Cell Cardiol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"617-25","DOI":"10.1016\/j.cardiores.2003.09.025","article-title":"Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.","volume":"60","author":"D Hausenloy","year":"2003","journal-title":"Cardiovasc Res."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1714-7","DOI":"10.1161\/01.CIR.0000126294.81407.7D","article-title":"Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.","volume":"109","author":"D Hausenloy","year":"2004","journal-title":"Circulation."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"H841-9","DOI":"10.1152\/ajpheart.00678.2003","article-title":"Preconditioning protects by inhibiting the mitochondrial permeability transition.","volume":"287","author":"D Hausenloy","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"H237-42","DOI":"10.1152\/ajpheart.01192.2004","article-title":"Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.","volume":"289","author":"S Shanmuganathan","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"189-202","DOI":"10.1007\/s00395-009-0010-x","article-title":"The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.","volume":"104","author":"D Hausenloy","year":"2009","journal-title":"Basic Res Cardiol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"235-54","DOI":"10.1007\/s10557-010-6237-9","article-title":"The second window of preconditioning (SWOP) where are we now?","volume":"24","author":"D Hausenloy","year":"2010","journal-title":"Cardiovasc Drugs Ther."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"132-42","DOI":"10.1016\/S0008-6363(03)00344-4","article-title":"Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion.","volume":"59","author":"Z Zhao","year":"2003","journal-title":"Cardiovasc Res."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"2143-8","DOI":"10.1161\/CIRCULATIONAHA.105.558122","article-title":"Postconditioning the human heart.","volume":"112","author":"P Staat","year":"2005","journal-title":"Circulation."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"173-91","DOI":"10.1016\/j.pharmthera.2007.06.005","article-title":"Preconditioning and postconditioning: united at reperfusion.","volume":"116","author":"D Hausenloy","year":"2007","journal-title":"Pharmacol Ther."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"626-34","DOI":"10.1160\/TH08-11-0734","article-title":"Signalling pathways in ischaemic postconditioning.","volume":"101","author":"D Hausenloy","year":"2009","journal-title":"Thromb Haemost."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"179-94","DOI":"10.1093\/cvr\/cvp062","article-title":"Cardioprotective growth factors.","volume":"83","author":"D Hausenloy","year":"2009","journal-title":"Cardiovasc Res."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"893-9","DOI":"10.1161\/01.CIR.87.3.893","article-title":"Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.","volume":"87","author":"K Przyklenk","year":"1993","journal-title":"Circulation."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"304-12","DOI":"10.1177\/1074248411411711","article-title":"Remote ischemic conditioning: a clinical trial's update.","volume":"16","author":"L Candilio","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"193-205","DOI":"10.2459\/JCM.0b013e328359dd7b","article-title":"Protection of organs other than the heart by remote ischemic conditioning.","volume":"14","author":"L Candilio","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"20-31","DOI":"10.1016\/j.ijcard.2014.06.018","article-title":"Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis.","volume":"176","author":"D Healy","year":"2014","journal-title":"Int J Cardiol."},{"key":"ref-36","first-page":"H1707-12","article-title":"Limb ischemia preconditions the heart against reperfusion tachyarrhythmia.","volume":"273","author":"T Oxman","year":"1997","journal-title":"Am J Physiol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1641-6","DOI":"10.1161\/01.CIR.96.5.1641","article-title":"Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit.","volume":"96","author":"Y Birnbaum","year":"1997","journal-title":"Circulation."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"2881-3","DOI":"10.1161\/01.CIR.0000043806.51912.9B","article-title":"Transient limb ischemia induces remote ischemic preconditioning in vivo.","volume":"106","author":"R Kharbanda","year":"2002","journal-title":"Circulation."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"377-86","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application.","volume":"79","author":"D Hausenloy","year":"2008","journal-title":"Cardiovasc Res."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"1601-10","DOI":"10.1161\/CIRCRESAHA.114.303822","article-title":"Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.","volume":"114","author":"T Rassaf","year":"2014","journal-title":"Circ Res."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00395-014-0423-z","article-title":"MicroRNA-144 is a circulating effector of remote ischemic preconditioning.","volume":"109","author":"J Li","year":"2014","journal-title":"Basic Res Cardiol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00395-013-0377-6","article-title":"Remote ischaemic preconditioning involves signalling through the SDF-1\u03b1\/CXCR4 signalling axis.","volume":"108","author":"S Davidson","year":"2013","journal-title":"Basic Res Cardiol."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"651-5","DOI":"10.1007\/s00395-010-0099-y","article-title":"The neural and humoral pathways in remote limb ischemic preconditioning.","volume":"105","author":"S Lim","year":"2010","journal-title":"Basic Res Cardiol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00395-016-0568-z","article-title":"Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning.","volume":"111","author":"J Pickard","year":"2016","journal-title":"Basic Res Cardiol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"276-7","DOI":"10.1016\/0140-6736(93)91819-8","article-title":"Preconditioning the human myocardium.","volume":"342","author":"D Yellon","year":"1993","journal-title":"Lancet."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"314-8","DOI":"10.1136\/hrt.77.4.314","article-title":"Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery.","volume":"77","author":"D Jenkins","year":"1997","journal-title":"Heart."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"985-94","DOI":"10.1016\/j.ejcts.2008.07.062","article-title":"Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials.","volume":"34","author":"S Walsh","year":"2008","journal-title":"Eur J Cardiothorac Surg."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"1373-4","DOI":"10.1016\/j.jtcvs.2007.01.028","article-title":"Postconditioning in cardiac surgery for tetralogy of Fallot.","volume":"133","author":"W Luo","year":"2007","journal-title":"J Thorac Cardiovasc Surg."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"203-8","DOI":"10.1016\/j.ejcts.2007.11.010","article-title":"Effect of ischemic postconditioning in adult valve replacement.","volume":"33","author":"W Luo","year":"2008","journal-title":"Eur J Cardiothorac Surg."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"17-21","DOI":"10.1510\/icvts.2008.189373","article-title":"Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot.","volume":"8","author":"B Li","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"493-6","DOI":"10.1006\/phrs.1999.0611","article-title":"Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery?","volume":"41","author":"B Gunaydin","year":"2000","journal-title":"Pharmacol Res."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"2277-82","DOI":"10.1016\/j.jacc.2006.01.066","article-title":"Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans.","volume":"47","author":"M Cheung","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"575-9","DOI":"10.1016\/S0140-6736(07)61296-3","article-title":"Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.","volume":"370","author":"D Hausenloy","year":"2007","journal-title":"Lancet."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00395-014-0453-6","article-title":"Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop.","volume":"110","author":"J Pickard","year":"2015","journal-title":"Basic Res Cardiol."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"732-48","DOI":"10.1111\/anae.12973","article-title":"Remote ischaemic conditioning: cardiac protection from afar.","volume":"70","author":"V Sivaraman","year":"2015","journal-title":"Anaesthesia."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"1067-77","DOI":"10.1136\/heartjnl-2014-306531","article-title":"Ischaemic conditioning: are we there yet?","volume":"101","author":"H Bulluck","year":"2015","journal-title":"Heart."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"193-209","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury.","volume":"13","author":"D Hausenloy","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"ref-58","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.","author":"D Hausenloy","year":"2017","journal-title":"Cardiovasc Res."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"597-604","DOI":"10.1016\/S0140-6736(13)61450-6","article-title":"Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.","volume":"382","author":"M Thielmann","year":"2013","journal-title":"Lancet."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"176-83","DOI":"10.1093\/eurheartj\/eht346","article-title":"Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial.","volume":"35","author":"D Hong","year":"2014","journal-title":"Eur Heart J."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"1397-407","DOI":"10.1056\/NEJMoa1413579","article-title":"A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery.","volume":"373","author":"P Meybohm","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"1408-17","DOI":"10.1056\/NEJMoa1413534","article-title":"Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.","volume":"373","author":"D Hausenloy","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"977-87","DOI":"10.1016\/j.ejcts.2009.02.014","article-title":"'Conditioning' the heart during surgery.","volume":"35","author":"V Venugopal","year":"2009","journal-title":"Eur J Cardiothorac Surg."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"2764-5","DOI":"10.1016\/j.jacc.2015.02.082","article-title":"Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis.","volume":"65","author":"D Yellon","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"727-34","DOI":"10.1016\/S0140-6736(09)62001-8","article-title":"Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.","volume":"375","author":"H Botker","year":"2010","journal-title":"Lancet."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"49-55","DOI":"10.1016\/j.jcin.2009.10.015","article-title":"Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action.","volume":"3","author":"I Rentoukas","year":"2010","journal-title":"JACC Cardiovasc Interv."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1055-63","DOI":"10.1016\/j.jcin.2013.05.011","article-title":"Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.","volume":"6","author":"G Crimi","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"178-88","DOI":"10.1016\/j.jcin.2014.05.015","article-title":"Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction.","volume":"8","author":"S White","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00395-013-0400-y","article-title":"The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction.","volume":"109","author":"F Prunier","year":"2014","journal-title":"Basic Res Cardiol."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"3049-57","DOI":"10.1093\/eurheartj\/ehv463","article-title":"Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.","volume":"36","author":"I Eitel","year":"2015","journal-title":"Eur Heart J."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"596-603","DOI":"10.2143\/AC.71.5.3167504","article-title":"Remote ischaemic preconditioning reduces myocardial ischaemic reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"71","author":"Z Liu","year":"2016","journal-title":"Acta Cardiol."},{"key":"ref-72","first-page":"1846-8","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.","volume":"36","author":"D Hausenloy","year":"2015","journal-title":"Eur Heart J."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00395-016-0529-6","article-title":"The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection.","volume":"111","author":"J Johnsen","year":"2016","journal-title":"Basic Res Cardiol."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"436-45","DOI":"10.1258\/jrsm.2012.120049","article-title":"A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery.","volume":"105","author":"J Pilcher","year":"2012","journal-title":"J R Soc Med."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"S53-9","DOI":"10.1161\/CIRCULATIONAHA.109.926667","article-title":"Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?","volume":"122","author":"I Rahman","year":"2010","journal-title":"Circulation."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00395-012-0256-6","article-title":"A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol.","volume":"107","author":"P Young","year":"2012","journal-title":"Basic Res Cardiol."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"399-411","DOI":"10.1093\/cvr\/cvu225","article-title":"ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.","volume":"104","author":"S Lecour","year":"2014","journal-title":"Cardiovasc Res."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"1142-74","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.","volume":"66","author":"P Ferdinandy","year":"2014","journal-title":"Pharmacol Rev."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"1740-6","DOI":"10.1111\/j.1582-4934.2009.00796.x","article-title":"Preconditioning the diabetic human myocardium.","volume":"14","author":"V Sivaraman","year":"2010","journal-title":"J Cell Mol Med."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"694-704","DOI":"10.1093\/cvr\/cvt140","article-title":"Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.","volume":"99","author":"H Whittington","year":"2013","journal-title":"Cardiovasc Res."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"30-8","DOI":"10.1111\/j.1399-6576.2011.02585.x","article-title":"Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.","volume":"56","author":"E Kottenberg","year":"2012","journal-title":"Acta Anaesthesiol Scand."},{"key":"ref-82","first-page":"4-8","article-title":"[Protein Kinase C Expression Following Remote Ischemic Preconditioning in Cardiac Surgery].","volume":"60","author":"A Bautin","year":"2015","journal-title":"Anesteziol Reanimatol."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"1567-71","DOI":"10.1136\/hrt.2008.155770","article-title":"Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial.","volume":"95","author":"V Venugopal","year":"2009","journal-title":"Heart."},{"key":"ref-84","doi-asserted-by":"publisher","first-page":"e21-6","DOI":"10.1016\/j.jss.2010.06.016","article-title":"Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial.","volume":"164","author":"L Li","year":"2010","journal-title":"J Surg Res."},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"360-9","DOI":"10.1016\/S0008-6363(99)00365-X","article-title":"Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition.","volume":"45","author":"S Javadov","year":"2000","journal-title":"Cardiovasc Res."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"413-20","DOI":"10.1177\/15353702-0323006-09","article-title":"Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass.","volume":"230","author":"K Lim","year":"2005","journal-title":"Exp Biol Med (Maywood)."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/6-563\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-563\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/6-563\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T11:13:36Z","timestamp":1553253216000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/6-563\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":86,"URL":"https:\/\/doi.org\/10.12688\/f1000research.10963.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.11817.r22040","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.11817.r21294","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.11817.r22041","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/6-563\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.11817.r22040, Fabrice Prunier, Department of Cardiology, CHU Angers, Angers, France, 25 Apr 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-563\/v1#referee-response-22040","order":0,"name":"referee-response-22040","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.11817.r22041, Andreas Goetzenich, RWTH Aachen University, Aachen, Germany, 25 Apr 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-563\/v1#referee-response-22041","order":1,"name":"referee-response-22041","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.11817.r21294, Petra Kleinbongard, West German Heart and Vascular Centre, University of Essen Medical School, Essen, Germany, 25 Apr 2017, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/6-563\/v1#referee-response-21294","order":2,"name":"referee-response-21294","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by the British Heart Foundation (FS\/10\/039\/28270), the Rosetrees Trust, Duke-NUS Medical School, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication).","order":0,"name":"copyright-info","label":"Copyright"}]}}